FDA Bans Vioxx And Bextra Critic From Advisory Panel Meeting A drug safety expert says his invitation to participate in a meeting on the risks of arthritis drugs like Vioxx and Bextra has been rescinded by government officials because he publicly expressed concerns about the medications.